載入...
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Imipenem/cilastatin/relebactam (Recarbrio™) is an intravenously administered combination of the carbapenem imipenem, the renal dehydropeptidase-I inhibitor cilastatin, and the novel β-lactamase inhibitor relebactam. Relebactam is a potent inhibitor of class A and class C β-lactamases, conferring imi...
Na minha lista:
| 發表在: | Drugs |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905759/ https://ncbi.nlm.nih.gov/pubmed/33630278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01471-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|